U.S. federal trademark · Serial No. 79150577 · Reg. No. 4779479
Pharmaceutical preparations for treatment of proliferative diseases, namely, pharmaceutical preparations for treatment of cancer, tumors, carcinoma or blastoma; pharmaceutical preparations comprising an anti-VEGF (vascular endothelial growth factor) monoclonal antibody, namely, pharmaceutical preparations comprising an anti-VEGF (vascular endothelial growth factor) monoclonal antibody for treatment of cancer, tumors, carcinoma or blastoma
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.